The effects of adjuvant endocrine therapy on long-term outcomes from ductal carcinoma in situ: a systematic review and meta-analysis
Background: Although adjuvant endocrine therapy (ET) is a standard treatment for hormone receptor positive ductal carcinoma in situ (DCIS), its use is variably recommended by clinicians. This paper reviewed the effects of ET in relation to recurrence and survival across diverse populations. Methods:...
Saved in:
| Main Authors: | Qian Chen, Ian Campbell, Mark Elwood, Alana Cavadino, Phyu Sin Aye, Sandar Tin Tin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-08-01
|
| Series: | Breast |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S0960977625005387 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Management of Ductal Carcinoma In Situ: An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline
by: Muriel Brackstone, et al.
Published: (2024-12-01) -
Analysis of ductal carcinoma in situ by self-reported race reveals molecular differences related to outcome
by: Siri H. Strand, et al.
Published: (2024-09-01) -
Adjuvant endocrine treatment strategies for non-metastatic breast cancer: a network meta-analysisResearch in context
by: Andri Papakonstantinou, et al.
Published: (2025-03-01) -
MODERN VIEWS ON THE ROLE OF OVARIAN SUPPRESSION IN THE TREATMENT OF PATIENTS WITH HORMONE-DEPENDENT BREAST CANCER: SABCS-2017 NEWS
by: A. A. Bozhok
Published: (2018-04-01) -
Exploration of the breast ductal carcinoma in situ signature and its prognostic implications
by: Jiao Zhang, et al.
Published: (2023-02-01)